Xunling Biotech

Hangzhou Xunling Biotech Co., Ltd. is a national high-tech enterprise founded by returneesspecializing in the field of animal medical testing. The company leverages two cutting-edgetechnologies, Next-Generation Sequencing (NGS) and isothermal amplification, to provide comprehensive animal disease diagnostic solutions for clients. Xunling Biotech has inde-pendently developed a world-leading clinical microbial genome sequencing and bioinformatics analysis system, and has established an extensive clinical microbial database containing over 30,000 species of bacteria, fungi, viruses, and parasites. In addition, the company has introduced automated equipment such as a pathogen metagenomic sequencing system, as well as innovative product lines including whole-genome sequencing for pathogen drug resistance.

As an integrated one-stop provider encompassing R&D, production, sales, and service, Xunling Biotech has independently developed a series of internationally advanced automated testing instruments and matching reagents, capable of meeting diverse application needs across pets, livestock, aquaculture, and forestry. The company has established close collaborations with internationally renowned universities, major animal medical institutions, and research organizations across China to develop AI and big data-powered auxiliary diagnostic systems, driving high-quality advancements in cutting-edge animal medicine.

Amid today's wave of IT application and digitalization across industries, Xunling Biotech upholds its core values of "Focus, Co-creation, and Altruism," guided by the corporate vision of "Becoming an Outstanding Leader in Animal Diagnostics".Through innovation-driven development and deep dedication to animal medical diagnestics, the company practices the"One Health" concept, striving to provide customers with more accurate and efficient animal medical testing services while promoting sustained progress in the industry.